005500.KS

Samjin Pharmaceuticals Co., Ltd. [005500.KS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

005500.KS Stock Summary

Earnings have grown 6.6% per last year.

The Moving Average Convergence Divergence (MACD) for 005500.KS recently turned positive (within last 10 days).

Top 10 Correlated ETFs

005500.KS

Top 10 Correlated Stocks

005500.KS

In the News

005500.KS Financial details

Company Rating

Market Cap

254.86B

Income

20.09B

Revenue

292.13B

Book val./share

Cash/share

Dividend

800

Dividend %

3.83%

Employees

586

Optionable

Shortable

Yes

Earnings

13 May 2024

P/E

Forward P/E

PEG

-15.36

P/S

0.89

P/B

1.02

P/C

P/FCF

-17.51

Quick Ratio

Current Ratio

1.08

Debt / Equity

LT Debt / Equity

EPS (TTM)

1.55K

EPS next Y

EPS next Q

EPS this Y

-15.52%

EPS next Y

EPS next 5Y

EPS last 5Y

9.74%

Revenue last 5Y

3.84%

Revenue Q/Q

7.48%

EPS Q/Q

135.11%

SMA20

0.62%

SMA50

0.34%

SMA100

-6.32%

Inst Own

Inst Trans

ROA

ROE

ROC

0.07%

Gross Margin

41%

Oper. Margin

Profit Margin

Payout

Shs Outstand

Shs Float

Target Price

52W Range

19870.0-25000.0

52W High

-28.68%

52W Low

-10.27%

RSI

59.06

Rel Volume

0.27

Avg Volume

29.62K

Volume

7.92K

Perf Week

0.56%

Perf Month

0.28%

Perf Quarter

-1.65%

Perf Half Y

-1.38%

Beta

0.31

Volatility

43.89%, 299.77%

Prev Close

-0.06%

Price

17830

Change

0.34%

005500.KS Financial Performance

005500.KS Dividend History

005500.KS Frequently Asked Questions

What is Samjin Pharmaceuticals Co., Ltd. stock symbol ?

Samjin Pharmaceuticals Co., Ltd. is a KR stock and trading under the symbol 005500.KS

What is Samjin Pharmaceuticals Co., Ltd. stock quote today ?

Samjin Pharmaceuticals Co., Ltd. stock price is $17830 today.

Is Samjin Pharmaceuticals Co., Ltd. stock public?

Yes, Samjin Pharmaceuticals Co., Ltd. is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 29.62K
Market Capitalization 254.86B
Employee 586
CEO Yong-Joo Choi
Headquarters Seoul,KR
IPO Date 2005-09-29
Website https://www.samjinpharm.co.kr

Samjin Pharmaceuticals Co., Ltd. engages in the research and development of pharmaceutical products in Korea. The company's products include SA001, a clinical Phase II product for the treatment of dry eye and sjogren syndrome; SJP1803/1804, a preclinical stage product for the treatment of macular degeneration; SJP601 and SJP1602 preclinical stage products for the treatment of cancer; SPJ1604 and SPJ003 clinical phase products for the treatment of cancer and diabetes; and SJP1901, SJP1902, SJP1801, and SJP006 biological testing stage products for the treatment of cancer, fibrosis, cancer immunotherapy, alzheimer's disease, Parkinson's disease, and anti-viral disease. The company was founded in 1968 and is headquartered in Seoul, South Korea.